Caribou Biosciences, Inc. Public Float
Caribou Biosciences, Inc. (CRBU) had Public Float of $112.50 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $112.50M.
- 2024-06-30: Entity Public Float $141.40M.
- 2023-06-30: Entity Public Float $263.40M.
- 2022-06-30: Entity Public Float $308.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $112.50M 10-K · filed 2026-03-05 |
| 2024-06-30 | $141.40M 10-K · filed 2025-03-10 |
| 2023-06-30 | $263.40M 10-K · filed 2024-03-11 |
| 2022-06-30 | $308.40M 10-K · filed 2023-03-09 |
| 2021-06-30 | $538.15M 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |